←
Tim Friede559 posts
Tim Friede avatar

Tim Friede

@tim_friede

Statistician at the University Medical Center Göttingen (UMG) Views are my own. @yourUMG @uniGoettingen

◷ Joined February 2016▧ 33 Photos and videos
NEJM avatar
⟳ Tim Friede retweeted
NEJM@NEJM·May 28

A video shows engineered heart muscle made up of allogeneic induced pluripotent stem-cell–derived cardiomyocytes and stromal cells for cardiac remuscularization in patients with heart failure. Read the full BioVAT-HF study results to learn more: nej.md/4nQ3Knc

0:12
DocBio🇺🇦🇨🇦🇮🇱🇪🇺🇬🇱🇩🇰🤝🇩🇪🌍 avatar
⟳ Tim Friede retweeted
DocBio🇺🇦🇨🇦🇮🇱🇪🇺🇬🇱🇩🇰🤝🇩🇪🌍@DocBio1509·May 29

Stem-Cell–Derived Biologic Ventricular Assist Tissue in Heart Failure | New England Journal of Medicine 👍👍👍 @dzhk_germany @pharmaumg @tim_friede nejm.org/doi/full/10.1056/NE…

NEJM avatar
⟳ Tim Friede retweeted
NEJM@NEJM·Mar 18

Among patients with atrial fibrillation at high risk for stroke and bleeding, left atrial appendage closure was not noninferior to medical therapy in reducing the risk of stroke, embolism, major bleeding, or death at 3 years. Full CLOSURE-AF trial results: nejm.org/doi/full/10.1056/NE… Editorial: Left Atrial Appendage Closure — Another Overused Method in Cardiology? nejm.org/doi/full/10.1056/NE…

Post attachment
Berry Consultants avatar
⟳ Tim Friede retweeted
Berry Consultants@BerryConsultant·15 Sep 2025

Prof. Frank Harrell, a leading figure in Bayesian biostatistics and experienced FDA advisor, joins Dr. Scott Berry on "In the Interim…" for an unfiltered assessment of statistical barriers and regulatory realities shaping clinical trial design. Prof. Harrell addresses the slow adoption of Bayesian approaches within the clinical trial community, critical flaws in type 1 error fixation, and the value of longitudinal and ordinal outcome modeling. Harrell describes both the influence of Dr. Don Berry and the ongoing effort to guide U.S. regulatory frameworks. Listen to this fascinating conversation today to learn more about the Bayesian approach to clinical trials: berryconsultants.com/resourc…

Post attachment
IBS avatar
⟳ Tim Friede retweeted
IBS@IBSstats·5 Sep 2025

🚀 Big news: IBS has a new look online! 🌐 Modern homepage 🎨 Fresh branding 🧭 Easier navigation 👥 Same great community Check out the refreshed IBS website today → biometricsociety.org/home

Post attachment
IBS avatar
⟳ Tim Friede retweeted
IBS@IBSstats·2 Sep 2025

🏆 IBS is now accepting nominations for three major awards: Honorary Life Membership, the Rob Kempton Award, and the Award for Outstanding Contribution to IBS. Submit by 31 Oct 2025. Winners honored at #IBC2026 in Seoul. members.biometricsociety.org…

Post attachment
Richard Riley (R²) avatar
⟳ Tim Friede retweeted
Richard Riley (R²)@Richard_D_Riley·2 Sep 2025

*NEW COURSE* "Individual Participant Data (IPD) Meta-Analysis Projects: A Practical Introduction" 📅 23-24 Sept 2025 | Online For all researchers considering or embarking on IPDMA projects tinyurl.com/3y7phy86

IBS avatar
⟳ Tim Friede retweeted
IBS@IBSstats·27 Aug 2025

📢 Call for Abstracts is OPEN! Present your research at IBC2026 in Seoul | 12–16 July 2026. Contributed oral & poster sessions welcome across statistics, data science & biosciences. 🗓 Submit by 3 Nov 2025 🔗members.biometricsociety.org…

Post attachment
Tim Friede avatar
Tim Friede@tim_friede·27 May 2025

Random-effects meta-analyis of a single study? Yes, this makes sense e.g. when deriving a meta-analytic predictive (MAP) prior for the analysis of another study. In this setting there are close links to power priors and bias allowance models. arxiv.org/abs/2505.15502

ESCAPE Project avatar
⟳ Tim Friede retweeted
ESCAPE Project@ESCAPEProjecteu·13 May 2025

💙 Interested in ESCAPE Videos? Check out our video playlist, where we break down key aspects of the project, from our innovative Blended Collaborative Care (BCC) approach to the role of care managers and digital health technologies. 📺 Watch here: bit.ly/3Edl2sa

Post attachment